Skip to content

Group-based support for type 2 diabetes patients (1 - 3 years post-diagnosis) and partners.

Living with diabetes: Development and evaluation of a family-based intervention to strengthen adaptive illness perceptions in patients with type 2 diabetes (1 - 3 years post-diagnosis) and their partners.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22987
Enrollment
200
Registered
2012-02-21
Start date
2012-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary care, Diabetes Mellitus type 2, Self-management.

Interventions

The intervention is based on the Common-Sense Model of Self-Regulation (CSM) and social learning theories. The intervention consists of three monthly group-based sessions of 2 hours, with a follow-up
to what extent where the goals reached and what barriers are perceived/encountered? Discussing (un)helpful supportive interactions and explore personal support needs. Including partner support in the

Sponsors

NIVEL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with type 2 diabetes, with a known illness duration of 1 - 3 years; 2. Score of 1 or more on a screener measuring perceived burden of diabetes.

Exclusion criteria

Exclusion criteria: 1. No sufficient understanding of the Dutch language; 2. No sufficient mental capabilities; 3. Suffering from severe psychological or psychiatric problems.

Design outcomes

Primary

MeasureTime frame
1. Health-related quality of life, both generic and diabetes-specific. This will be measured as diabetes distress and well-being; 2. Self-management behaviour.

Secondary

MeasureTime frame
1. Illness perceptions; 2. Spousal support; 3. Patient activation.

Contacts

Public ContactA.L. Puffelen, van

NIVEL P.O. box 1568

a.vanpuffelen@nivel.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)